关注
Vulto AG
Vulto AG
Hospital Pharmacy, ErasmusMC Rotterdam, The Netherlands and KU Leuven, Belgium
在 erasmusmc.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Overriding of drug safety alerts in computerized physician order entry
H Van Der Sijs, J Aarts, A Vulto, M Berg
Journal of the American Medical Informatics Association 13 (2), 138-147, 2006
12472006
Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience.
CH Lamers, S Sleijfer, AG Vulto, WH Kruit, M Kliffen, R Debets, ...
Journal of clinical oncology: official journal of the American Society of …, 2006
11252006
Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity
CHJ Lamers, S Sleijfer, S Van Steenbergen, P Van Elzakker, ...
Molecular therapy 21 (4), 904-912, 2013
8032013
Long-term intravenous treatment of Pompe disease with recombinant human α-glucosidase from milk
JMP Van den Hout, JHJ Kamphoven, LPF Winkel, WFM Arts, JBCD Klerk, ...
Pediatrics 113 (5), e448-e457, 2004
4212004
Recombinant human α-glucosidase from rabbit milk in Pompe patients
H Van den Hout, AJJ Reuser, AG Vulto, MCB Loonen, A Cromme-Dijkhuis, ...
The Lancet 356 (9227), 397-398, 2000
4172000
glycyrrhizin as a potential treatment for chronic hepatitis C.
TG Van Rossum, AG Vulto, RA De Man, JT Brouwer, SW Schalm
Alimentary pharmacology & therapeutics 12 (3), 199-205, 1998
3781998
Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial
BJ Rijnders, JJ Cornelissen, L Slobbe, MJ Becker, JK Doorduijn, ...
Clinical infectious diseases 46 (9), 1401-1408, 2008
3362008
Enzyme replacement therapy in late‐onset Pompe's disease: a three‐year follow‐up
LPF Winkel, JMP Van den Hout, JHJ Kamphoven, JAM Disseldorp, ...
Annals of neurology 55 (4), 495-502, 2004
2772004
Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double‐blind, randomized, placebo‐controlled phase I/II trial
TGV Rossum, AG Vulto, WCJ Hop, JT Brouwer, HG Niesters, SW Schalm
Journal of gastroenterology and hepatology 14 (11), 1093-1099, 1999
2461999
Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function
AH van den Meiracker, RGA Baggen, S Pauli, A Lindemans, AG Vulto, ...
Journal of hypertension 24 (11), 2285-2292, 2006
2442006
Policies for biosimilar uptake in Europe: an overview
E Moorkens, AG Vulto, I Huys, P Dylst, B Godman, S Keuerleber, B Claus, ...
PloS one 12 (12), e0190147, 2017
2392017
Turning off frequently overridden drug alerts: limited opportunities for doing it safely
H Van Der Sijs, J Aarts, T Van Gelder, M Berg, A Vulto
Journal of the American Medical Informatics Association 15 (4), 439-448, 2008
2042008
A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital
GW 't Jong, AG Vulto, M de Hoog, KJM Schimmel, D Tibboel, ...
Pediatrics 108 (5), 1089-1093, 2001
2012001
Guidelines for the practical stability studies of anticancer drugs: a European consensus conference
C Bardin, A Astier, A Vulto, G Sewell, J Vigneron, R Trittler, M Daouphars, ...
Annales pharmaceutiques francaises 69 (4), 221-231, 2011
1992011
Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C
TGJ Van Rossum, AG Vulto, WCJ Hop, SW Schalm
Official journal of the American College of Gastroenterology| ACG 96 (8 …, 2001
1962001
Genetic Variation in the CYP2D6 Gene Is Associated With a Lower Heart Rate and Blood Pressure in β‐Blocker Users
MJ Bijl, LE Visser, RHN Van Schaik, JA Kors, JCM Witteman, A Hofman, ...
Clinical Pharmacology & Therapeutics 85 (1), 45-50, 2009
1812009
The process defines the product: what really matters in biosimilar design and production?
AG Vulto, OA Jaquez
Rheumatology 56 (suppl_4), iv14-iv29, 2017
1702017
The CYP2D6* 4 polymorphism affects breast cancer survival in tamoxifen users
MJ Bijl, RHN van Schaik, LA Lammers, A Hofman, AG Vulto, T van Gelder, ...
Breast cancer research and treatment 118, 125-130, 2009
1552009
Acute renal failure after local gentamicin treatment in an infected total knee arthroplasty
TM van Raaij, LE Visser, AG Vulto, JAN Verhaar
The Journal of arthroplasty 17 (7), 948-950, 2002
1512002
Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel
FK Engels, AJ Ten Tije, SD Baker, CKK Lee, WJ Loos, AG Vulto, J Verweij, ...
Clinical Pharmacology & Therapeutics 75 (5), 448-454, 2004
1432004
系统目前无法执行此操作,请稍后再试。
文章 1–20